Pseudo-Kappa Light Chain Restricted Hematogones in Patients Receiving Daratumumab

Pseudo-Kappa Light Chain Restricted Hematogones in Patients Receiving Daratumumab [Turk J Hematol]

Turk J Hematol. 2022; 39(1): 80-81 | DOI: 10.4274/tjh.galenos.2021.2021.0480

Pseudo-Kappa Light Chain Restricted Hematogones in Patients Receiving Daratumumab

Hamza Tariq¹, Urooj Zahra²
¹Rush University Medical Center, Chicago, Illinois, USA
²Doctors Hospital and Medical Center, Punjab, Pakistan

Keywords: Daratumumab, Hematogones, Kappa, Cytometry, Artifactual

Daratumumab Alan Hastalarda Yalanc�-Kappa Hafif Zincir S�n�rl� Hematogonlar

Hamza Tariq¹, Urooj Zahra²
¹Rush University Medical Center, Chicago, Illinois, USA
²Doctors Hospital and Medical Center, Punjab, Pakistan

Anahtar Kelimeler: Daratumumab, Hematogonlar, Sitometri, Yapay

Hamza Tariq, Urooj Zahra. Pseudo-Kappa Light Chain Restricted Hematogones in Patients Receiving Daratumumab. Turk J Hematol. 2022; 39(1): 80-81

Corresponding Author: Hamza Tariq

TOOLS

Full Text PDF

Download citation

RIS

EndNote

BibTex

Medlars

Procite

Reference Manager

Share with email

Similar articles

PubMed

Google Scholar

In authors and institutes

In titles and abstracts

In keywords

In all


	E-ISSN: 1308-5263
Archive Most Accessed Articles Most Cited Articles Aims and Scope Instructions For Authors Editorial Board Advisory Board Manuscript Submission Why to Submit Search Contact